Navigation Links
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Date:2/29/2008

perglycemia should also undergo fasting blood glucose

testing. There have been few reports of hyperglycemia with ABILIFY

ABILIFY may be associated with orthostatic hypotension and should be used with caution in patients with known cardiovascular disease, cerebrovascular disease, or conditions which would predispose them to hypotension.

As with other antipsychotic drugs, ABILIFY should be used with caution in patients with a history of seizures or with conditions that lower the seizure threshold.

Like other antipsychotics, ABILIFY may have the potential to impair judgment, thinking, or motor skills. Patients should not drive or operate hazardous machinery until they are certain ABILIFY does not affect them adversely.

Disruption of the body's ability to reduce core body temperature has been attributed to antipsychotics. Appropriate care is advised for patients who may exercise strenuously, be exposed to extreme heat, receive concomitant medication with anticholinergic activity, or be subject to dehydration.

Esophageal dysmotility and aspiration have been associated with antipsychotic drug use, including ABILIFY; use caution in patients at risk for aspiration pneumonia.

The possibility of a suicide attempt is inherent in psychotic illnesses, bipolar disorder, and major depressive disorder, and close supervision of high-risk patients should accompany drug therapy.

Physicians should advise patients to avoid alcohol while taking ABILIFY.

Strong CYP3A4 or CYP2D6 inhibitors increase ABILIFY drug concentrations when used concomitantly.

CYP3A4 inducers decrease ABILIFY drug concentrations when used concomitantly.

Commonly observed adverse reactions (greater than or equal to 5% incidence and at least twice the rate of placebo for ABILIFY vs placebo, respectively):
-- Adult patients with bipolar mania: constipation (13% vs 6%), akathisia

(15% vs 3%), sedation (8% vs 3%), tremor
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
2. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
5. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
6. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
7. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
10. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Cardium Therapeutics (NYSE Amex: CXM ) announced ... (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," at ... Conference held December 10-13, 2009 in St. Thomas, ... by top industry leaders and renowned researchers in ... Barbara K. Sosnowski, Cardium,s Vice President of Biologics ...
(Date:12/14/2009)... in Finland have gained access to more advanced ... from Varian Medical Systems (NYSE: VAR ... the Nordic region. Clinicians at Docrates Clinic in ... of radiotherapy to treat patients with multiple brain ... ,, RapidArc, which enables clinicians to deliver a ...
(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 According ... authority on medical technology market intelligence, Japan,s ... process has created a significant lag in ... country compared to other developed nations. ... Vascular Devices 2010 report finds, however, ...
Breaking Medicine Technology:Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 2Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 3Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 1Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 2Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 3Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 4Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 5Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 6Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 7ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 1ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 2ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 3ACTEMRA 28R 29 28tocilizumab 29 Studies to be Featured at the European League Against Rheumatism 28EULAR 29 Congress 47894 4SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 1SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 2SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 3
... Pharmacy, one,of the largest privately owned national specialty ... agreement with Genzyme Corporation to,administer their 2008 Renagel ... world,s largest biotechnology companies dedicated to products,and services ... and oncology., Diplomat will be the 2008 ...
... Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based biotechnology company ... "2008 Deal of the Year",award winner by Georgia ... million IPCAVD (Integrated Preclinical/Clinical AIDS VACCINE,Development grant) from ... The award will be presented at Georgia Bio,s ...
Other Medicine Technology:Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program 2GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 2GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 3GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 4
(Date:12/14/2009)... men whose disease had been treated, hadn,t spread, study ... appears to reduce the risk of death in male ... began in January 1986, included 668 men who,d been ... colon cancer that had not spread (nonmetastatic cancer). Every ... them about any new cancer and disease diagnoses, as ...
(Date:12/14/2009)... of scientists from the UC San Diego School of ... protein switch that helps prevent liver damage, including inflammation, ... understanding of how the protein, TAK1, works could lead ... and cancer. , "TAK1 appears to be a ... MD, professor of medicine and Dean of the UC ...
(Date:12/14/2009)... mental functioning , , , MONDAY, Dec. 14 (HealthDay News) ... to live longer than those who look older than ... came from research that involved 1,826 Danish twins, aged ... tests and then had their faces photographed. Three groups ... age they perceived the participants to be. Twins were ...
(Date:12/14/2009)... who have been certified by the Alzheimer’s Association Care Academy. ... services to San Francisco Bay Area families. , ... ... -- Professional HealthCare at Home, the San Francisco Bay Area’s ... personal caregiver and hospice services, has expanded its staffing expertise ...
(Date:12/14/2009)... YORK, Dec. 14 Josie Raper, a 29 year-old ... in six months with the help of the Dr. Siegal,s ... on the Joy Fit Club segment on NBC,s Today Show. ... Joy Bauer, airs twice a month and salutes those who ... in 2007 and has kept it off for two years. ...
Breaking Medicine News(10 mins):Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Looking Younger Than Your Age May Mean Longer Life 2Health News:Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4
... (IFFIm) will be providing life saving vaccines for millions ... costing $4 billion to be funded by the European ... scheme, the International Finance Facility for Immunization (IFF), would ... the next 10 years and another five million thereafter. ...
... found that women with daily stress in their life have ... study have been published in the British Medical Journal. The ... period of 18 years.// The estrogen which ... of breast cancer. Researchers have found that stress reduced the ...
... of The American Journal of Medicine, researchers from St. Joseph ... risk factor for venous thromboembolic disease in people, more to ... ,Since 1927, obesity has been thought to be a risk ... proportion of obesity in the general population, previous studies have ...
... a married couple in West Bengal. The duo preferred to ... everyday. ,In an act driven// by social ostracism, a 29-year-old ... hanged himself in the Durgapur industrial town of south Bengal's ... Sarkar were a happy couple since their love marriage four ...
... Depression in people may accelerate the heart conditions by releasing ... a study of 32 people with heart failure, the 14 ... levels of this protein in their blood. ,The protein, ... large family of proteins called cytokines, chemical messengers that are ...
... University of California, San Diego, suggests that the clues ... of the genome sequences between man and chimpanzee but ... differences between the species: one, the discovery of the ... cells associated with human brain diseases; the second, a ...
Other Medicine News:Health News:European Countries To Fund $4 Billion For Vaccination For Poor Children’ 2
... you've come to demand in BD K-3000 ... K-4000 microkeratome is built upon. , ,The ... The front panel on the new console ... bright visual feedback., ,The BD K-4000 Microkeratome ...
... third-generation allergy test , 3gAllergy is a ... provides quantitative determination of allergen-specific IgE at ... and lot-to-lot reproducibility. The assay delivers reliable ... you identify, monitor and manage patients with ...
The properties of titanium alloy have been combined with a uniquely designed reverse radial tapping flute to produce a state-of-the-art fracture fixation system....
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
Medicine Products: